Tag: FDA De Novo classification
Masimo Announces Bridge, A Wearable Neurostimulation Device That Reduces Opioid Withdrawal Symptoms
Masimo, a medical technology company, announced Bridge, an opioid withdrawal solution. The drug-free device applies electrical impulses to the cranial nerves around the ear,...